#Netherlands #Eindhoven #Sirius Medical #Pintuition #World Cancer Day

Sirius Medical Secures Major Funding to Advance Cancer Care

In an impressive development announced on World Cancer Day, Sirius Medical, a pioneering medical device company based in the Netherlands, has successfully raised 10 million euros in scale-up funding. This investment marks a significant milestone in its quest to enhance its leading surgical marker navigation portfolio and expand its global reach.

Securing this funding was a concerted effort led by Invest-NL and Nextgen Ventures, and it also received backing from the De Groot Family Office along with established investors such as the Brabant Development Agency (BOM), Holland Capital, Curie Capital, and Team Holmium. This infusion of capital not only strengthens Sirius Medical’s existing operations but also aligns perfectly with its mission to innovate cancer care.

The funding comes at a crucial time as the medical community continues to fight against cancer. The Sirius Pintuition® navigation platform is already renowned among breast cancer surgeons globally for its wire-free localization, enabling precision in breast-conserving surgeries no matter the hospital setting. This new capital will allow the company to enhance the Pintuition system further and its innovative GPSDetect™ software platform, emphasizing user-friendliness and extending its applications across various surgical practices.

As Karin Steffens, senior investment manager at Invest-NL, explained, their healthcare focus revolves around investing in innovations that prioritize efficiency in patient care. Steffens emphasized, “Sirius Medical’s mission of developing sustainable technology solutions resonates with our goal to revolutionize healthcare.” This support demonstrates a collective determination to improve outcomes for women facing breast cancer and acknowledges the vital role that innovative technologies play in achieving that.

Bram Schermers, CEO of Sirius Medical, eloquently stated that announcing this funding milestone on World Cancer Day underscores the urgency of their mission. He credited the talented team at Sirius Medical and the groundbreaking Pintuition technology as key drivers behind this successful fundraising effort. Schermers articulated a clear ambition, expressing, “We are proud to continue contributing to the fight against cancer and look forward to the next phase of growth for Sirius Medical.”

The investment manager from NextGen Ventures, Roel Dekkers, recognized the exceptional capabilities and adaptability of the Sirius Medical leadership team, further highlighting the company’s readiness for expansion and the substantial growth opportunities within yet-to-be-tapped markets. This confirmation of confidence from industry experts not only solidifies the reputation of Sirius Medical but also fosters expectations for significant advancements in cancer care technology.

World Cancer Day, celebrated on February 4th annually, aims to raise awareness and inspire action in the global effort to combat cancer's pervasive impact. The resonance of this fundraising announcement during such an important occasion serves as a reminder of the ongoing challenges and collective efforts needed in the fight against this disease.

Sirius Medical traces its roots back to the Netherlands Cancer Institute and is fully committed to improving care for cancer patients. With its focus on delivering precise, affordable solutions for effective tumor removal, the company’s products, including the Sirius Pintuition system, are both CE-marked and FDA-cleared. As the company rapidly expands its network, now reaching over 250 centers and facilitating 35,000 procedures worldwide, it remains a beacon of innovation in the healthcare landscape.

For more information, you can visit their official website: Sirius Medical or connect with them on social media @SiriusMedical using the hashtag #siriuspintuition.